Search
for
Sort by
Research 331–360 of 1000+
- Real-World Effectiveness, Safety, and Tolerability of Cetosomal Minoxidil 5% Alone and a Fixed Drug Combination of Cetosomal Minoxidil 5% With Finasteride 0.1% in the Management of Androgenetic Alopecia (Inbilt Study)
- Dermoscopic evaluation of the efficacy of combination of topical spironolactone 5% and minoxidil 5% solutions in the treatment of androgenetic alopecia: A cross sectional‐comparative study
- Dupilumab Combined with Topical 5% Minoxidil for Severe Alopecia Areata in a 2-Year-Old Child with Type 2 Immune Features: A Case Report
- Dupilumab Combined with Topical 5% Minoxidil for Severe Alopecia Areata in a 2-Year-Old Child with Type 2 Immune Features: A Case Report
- Efficacy and safety of topical 5% minoxidil in treatment of androgenetic alopecia
- Microneedling kombinasi minoksidil 5% dengan steroid sistemik dan topikal pada pasien alopesia areata: laporan kasus
- comparative study between minoxidil 5% and micro-botulinum toxin effectiveness in treatment of female pattern androgenetic alopecia with dermoscopic evaluation
- A COMBINATION STUDY BETWEEN TOPICAL 5%MINOXIDIL AND TOPICAL PROCAPIL IN MEN WITH ANDROGENIC ALOPECIA
- A COMBINATION STUDY BETWEEN TOPICAL 5%MINOXIDIL AND TOPICAL PROCAPIL IN MEN WITH ANDROGENIC ALOPECIA
- Characteristics of Hypertrichosis Induced by 24-week Low-dose (5 mg Daily) Oral Minoxidil in Male Pattern Hair Loss Treatment
- COMPARITIVE STUDY OF TOPICAL MINOXIDIL (5%) PLUS FINASTERIDE (0.1%) VERSUS PLATELET-RICH PLASMA PLUS TOPICAL MINOXIDIL (5%) PLUS FINASTERIDE (0.1%) IN PATIENTS WITH ANDROGENIC ALOPECIA
- Comparison between Topical Minoxidil 5% Alone versus Combined with Dutasteride (Topical 0.02% through Microneedling or Oral 0.5 mg) in Treatment of Androgenetic Alopecia
- Oral minoxidil 7.5 mg for hair loss increases heart rate with no change in blood pressure in 24 h Holter and 24 h ambulatory blood pressure monitoring
- Combination of Minoxidil 5% with Carboxytherapy versus Minoxidil 5% Alone in Treatment of Female Pattern Hair Loss
- Relative Effects of Minoxidil 5%, Platelet-Rich Plasma, and Microneedling in Pattern Hair Loss: A Systematic Review and Network Meta-Analysis
- EFFICACY OF TOPICAL MINOXIDIL 5% AND BETAMETHASONE VALERATE 0.1% VERSUS BETAMETHASONE VALERATE 0.1% MONOTHERAPY IN NON-SEGMENTAL VITILIGO
- Efficacy of topical 5% minoxidil versus oral 5mg biotin versus topical minoxidil and oral biotin on hair growth velocity in men: a randomized, crossover clinical trial
- A Comparative Study between the Efficacy and Safety of 5% Minoxidil Solution and 5% Minoxidil Milky Lotion in the Treatment of Male Androgenic Alopecia.
- 남성형 탈모증 환자에 대한 5% Minoxidil 외용액의 공개 다기관 임상연구(제4상 임상시험)(대한모발학회 공동연구)
- Dermoscopic evaluation of the efficacy of combination of topical spironolactone 5% and minoxidil 5% solutions in the treatment of androgenetic alopecia, comparative study.
- A randomised trial of 5% minoxidil versus combination of 5% minoxidil and oral spironolactone in treatment of female pattern hair loss
- A comparative study of microneedling with PRP plus minoxidil (5%) and minoxidil (5%) alone in androgenetic alopecia
- Systemic cyproterone acetate and 5% minoxidil topical in the treatment of female pattern hair loss
- Minoxidil increases 17β-hydroxysteroid dehydrogenase and 5α-reductase activity of cultured human dermal papilla cells from balding scalp
- Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment
- Pustular allergic contact dermatitis from topical minoxidil 5%
- Efficacy and safety of oral minoxidil 5 mg daily during 24-week treatment in male androgenetic alopecia
- Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study
- Frontal edema due to topical application of %5 minoxidil solution following mesotherapy injections
- Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo‐controlled, double‐blind, noninferiority study